Daily Iowan – 4/29/2020
“A petition on the Lower Drug Prices Now website calls for Congress to require fair and reasonable prices for drugs developed using taxpayer-funded research, prevent drug companies from gaining exclusive patent rights to coronavirus drugs, and disclose details of contracts between the government and drug corporations.”
Maine Beacon – 4/29/2020
Democratic Reps. Jared Golden and Chellie Pingree say they support including safeguards against vaccine and treatment profiteering in future COVID-19 relief legislation.
There is a currently a proposal for legislation to require fair prices for all COVID-19 drugs or vaccines developed with taxpayer funds, require that no drug company be granted exclusivity for any COVID-19 vaccine or drug that may or may not be developed with taxpayer funds, and mandate that pharmaceutical manufacturers disclose how much public money they are using to create treatments and vaccines.
Leaders Urge Congress To Take Action In Next Relief Bill To Ensure All Workers Get Low Cost COVID Medicines
Congressmen Chuy Garcia and Steven Horsford joined Lower Drug Prices Now and frontline workers for a tele-town hall urging Congress to guarantee affordable medicines and vaccines for workers by preventing pandemic profiteering by drug corporations that received taxpayer funds for developing COVID treatments.
New Jersey — Today, Lower Drug Prices Now coalition partners Health Care Voter, New Jersey Citizen Action, and New Jersey Organizing Project joined together to tell Johnson & Johnson not to profiteer off of the coronavirus pandemic.
Roll Call – 4/22/20
A new drug pricing coalition will launch its first campaign Thursday, calling on lawmakers to ensure that vaccines or treatments for COVID-19 will be affordable for patients, according to information shared exclusively with CQ Roll Call.
Leaders Urge Congress To Take Action In Next Relief Bill To Ensure Drug Companies Can’t Exploit This Crisis
Former Senator Tom Harkin joined Lower Drug Prices Now, local groups and Iowans directly impacted by COVID-19, for a tele-town hall Tuesday at 6:00pm CT to urge Congress to take action to prevent pandemic profiteering by drug companies charged with developing COVID treatments and vaccines.
Politico Prescription Pulse – 4/17/2020
“Skeptics argued that the pledge has its limits, such as not-for-profit being on an emergency basis, not generally. J&J has also secured more than $600 million in government funding for its vaccine and antiviral efforts, leading some to argue the government should have an ultimate say in price.
“It really shouldn’t be up to the prescription drug companies,” said Margarida Jorge, national campaign director for Lower Drug Prices Now. “It’s like not this thing is going anywhere. We’re going to need it and we’re going to need it for the long term, like with the polio vaccine.”